Market Cap $8.926M
!


Corporate Spotlight
Memphasys Ltd is a listed Australian MedTech company (ASX: MEM) focussed on reproductive biotechnology. Driven by market needs, Memphasys is developing a portfolio of device, diagnostic and media products that address human and animal reproduction issues.
View the full Corporate Spotlight
LATEST INTERVIEW
Last update - 11.46am 29/07/2025 (20 minute delay)
?
Day | ||||||||
---|---|---|---|---|---|---|---|---|
Open | 0.5¢ | Day High | 0.5¢ | Day Low | 0.5¢ | |||
Daily Volume | 500000 |
Bids | Sellers | |||||
---|---|---|---|---|---|---|
Number | Price | Volume | Number | Price | Volume | |
22 | 0.4¢ | 13689877 | 7 | 0.5¢ | 4520722 |
Directors & Senior Management
Dr. David Ali | Chief Executive Officer, Executive Director |
Mr. Pablo Neyertz | Director of Finance |
Prof. John Aitken | Research Director |
Assoc. Prof. Hassan Bakos | Director of Operations |
Mr. Nick Gorring | Operations Manager |
Mr. Andrew Metcalfe | Company Secretary |
Ms. Lindley Edwards | Non-Executive Chairman of the Board |
Mr. Marjan Mikel | Non-Executive Director |
Mr. Michael Atkins | Independent Non-Executive Director |
Mr. Paul Martin Wright | Non-Executive Independent Director |
Data source: Refinitiv